APO RESEARCH · REPORT
Medical Drug and Device Microbiological Sterility Testing
Selected research
Industry Research
Medical Drug and Device Microbiological Sterility Testing Industry Research Report 2026
Market perspective
The global Medical Drug and Device Microbiological Sterility Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Medical Drug and Device Microbiological Sterility Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Medical Drug and Device Microbiological Sterility Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Medical Drug and Device Microbiological Sterility Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Medical Drug and Device Microbiological Sterility Testing include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings and Almac Group and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Medical Drug and Device Microbiological Sterility Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Drug and Device Microbiological Sterility Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Drug and Device Microbiological Sterility Testing Market by Company
Steris PLC
Charles River Laboratories International, Inc.
Thermo Fisher Scientific, Inc.
SGS S.A.
Sartorius AG
Sotera Health Company
Pacific Biolabs, Inc.
Laboratory Corporation of America Holdings
Almac Group
Pace Analytical Services, LLC
Medical Drug and Device Microbiological Sterility Testing Segment by Type
Bioburden Testing
Sterility Testing
Bacterial Endotoxin Testing
Medical Drug and Device Microbiological Sterility Testing Segment by Application
Medical Drugs
Medical Devices
Medical Drug and Device Microbiological Sterility Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Drug and Device Microbiological Sterility Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Drug and Device Microbiological Sterility Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Drug and Device Microbiological Sterility Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Drug and Device Microbiological Sterility Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bioburden Testing
- Sterility Testing
- Bacterial Endotoxin Testing
Applications
- Medical Drugs
- Medical Devices
Companies covered
- Steris PLC
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
- SGS S.A.
- Sartorius AG
- Sotera Health Company
- Pacific Biolabs, Inc.
- Laboratory Corporation of America Holdings
- Almac Group
- Pace Analytical Services, LLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Drug and Device Microbiological Sterility Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bioburden Testing
- 2.2.3 Sterility Testing
- 2.2.4 Bacterial Endotoxin Testing
- 2.3 Medical Drug and Device Microbiological Sterility Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Drugs
- 2.3.3 Medical Devices
- 2.4 Assumptions and Limitations
3 Medical Drug and Device Microbiological Sterility Testing Breakdown Data by Type
- 3.1 Global Medical Drug and Device Microbiological Sterility Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Drug and Device Microbiological Sterility Testing Forecasted Market Size by Type (2027-2032)
4 Medical Drug and Device Microbiological Sterility Testing Breakdown Data by Application
- 4.1 Global Medical Drug and Device Microbiological Sterility Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Drug and Device Microbiological Sterility Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Drug and Device Microbiological Sterility Testing Market Perspective (2021-2032)
- 5.2 Global Medical Drug and Device Microbiological Sterility Testing Growth Trends by Region
- 5.2.1 Global Medical Drug and Device Microbiological Sterility Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Drug and Device Microbiological Sterility Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Drug and Device Microbiological Sterility Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Drug and Device Microbiological Sterility Testing Market Dynamics
- 5.3.1 Medical Drug and Device Microbiological Sterility Testing Industry Trends
- 5.3.2 Medical Drug and Device Microbiological Sterility Testing Market Drivers
- 5.3.3 Medical Drug and Device Microbiological Sterility Testing Market Challenges
- 5.3.4 Medical Drug and Device Microbiological Sterility Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Drug and Device Microbiological Sterility Testing Players by Revenue
- 6.1.1 Global Top Medical Drug and Device Microbiological Sterility Testing Players by Revenue (2021-2026)
- 6.1.2 Global Medical Drug and Device Microbiological Sterility Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Drug and Device Microbiological Sterility Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Drug and Device Microbiological Sterility Testing Head Office and Area Served
- 6.4 Global Medical Drug and Device Microbiological Sterility Testing Players, Product Type & Application
- 6.5 Global Medical Drug and Device Microbiological Sterility Testing Manufacturers Established Date
- 6.6 Global Medical Drug and Device Microbiological Sterility Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
- 7.2 North America Medical Drug and Device Microbiological Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2021-2026)
- 7.4 North America Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
- 8.2 Europe Medical Drug and Device Microbiological Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2021-2026)
- 8.4 Europe Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
- 10.2 South America Medical Drug and Device Microbiological Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2021-2026)
- 10.4 South America Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Drug and Device Microbiological Sterility Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Steris PLC
- 12.1.1 Steris PLC Company Information
- 12.1.2 Steris PLC Business Overview
- 12.1.3 Steris PLC Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.1.4 Steris PLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.1.5 Steris PLC Recent Developments
- 12.2 Charles River Laboratories International, Inc.
- 12.2.1 Charles River Laboratories International, Inc. Company Information
- 12.2.2 Charles River Laboratories International, Inc. Business Overview
- 12.2.3 Charles River Laboratories International, Inc. Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.2.4 Charles River Laboratories International, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.2.5 Charles River Laboratories International, Inc. Recent Developments
- 12.3 Thermo Fisher Scientific, Inc.
- 12.3.1 Thermo Fisher Scientific, Inc. Company Information
- 12.3.2 Thermo Fisher Scientific, Inc. Business Overview
- 12.3.3 Thermo Fisher Scientific, Inc. Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.3.5 Thermo Fisher Scientific, Inc. Recent Developments
- 12.4 SGS S.A.
- 12.4.1 SGS S.A. Company Information
- 12.4.2 SGS S.A. Business Overview
- 12.4.3 SGS S.A. Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.4.4 SGS S.A. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.4.5 SGS S.A. Recent Developments
- 12.5 Sartorius AG
- 12.5.1 Sartorius AG Company Information
- 12.5.2 Sartorius AG Business Overview
- 12.5.3 Sartorius AG Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.5.4 Sartorius AG Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.5.5 Sartorius AG Recent Developments
- 12.6 Sotera Health Company
- 12.6.1 Sotera Health Company Company Information
- 12.6.2 Sotera Health Company Business Overview
- 12.6.3 Sotera Health Company Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.6.4 Sotera Health Company Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.6.5 Sotera Health Company Recent Developments
- 12.7 Pacific Biolabs, Inc.
- 12.7.1 Pacific Biolabs, Inc. Company Information
- 12.7.2 Pacific Biolabs, Inc. Business Overview
- 12.7.3 Pacific Biolabs, Inc. Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.7.4 Pacific Biolabs, Inc. Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.7.5 Pacific Biolabs, Inc. Recent Developments
- 12.8 Laboratory Corporation of America Holdings
- 12.8.1 Laboratory Corporation of America Holdings Company Information
- 12.8.2 Laboratory Corporation of America Holdings Business Overview
- 12.8.3 Laboratory Corporation of America Holdings Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.8.4 Laboratory Corporation of America Holdings Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.8.5 Laboratory Corporation of America Holdings Recent Developments
- 12.9 Almac Group
- 12.9.1 Almac Group Company Information
- 12.9.2 Almac Group Business Overview
- 12.9.3 Almac Group Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.9.4 Almac Group Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.9.5 Almac Group Recent Developments
- 12.10 Pace Analytical Services, LLC
- 12.10.1 Pace Analytical Services, LLC Company Information
- 12.10.2 Pace Analytical Services, LLC Business Overview
- 12.10.3 Pace Analytical Services, LLC Revenue in Medical Drug and Device Microbiological Sterility Testing Business (2021-2026)
- 12.10.4 Pace Analytical Services, LLC Medical Drug and Device Microbiological Sterility Testing Product Portfolio
- 12.10.5 Pace Analytical Services, LLC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst